Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing
- 25 September 2006
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 28 (2), 150-158
- https://doi.org/10.1002/humu.20400
Abstract
Although single base‐pair substitutions in splice junctions constitute at least 10% of all mutations causing human inherited disease, the factors that determine their phenotypic consequences at the RNA level remain to be fully elucidated. Employing a neural network for splice‐site recognition, we performed a meta‐analysis of 478 disease‐associated splicing mutations, in 38 different genes, for which detailed laboratory‐based mRNA phenotype assessment had been performed. Inspection of the ±50‐bp DNA sequence context of the mutations revealed that exon skipping was the preferred phenotype when the immediate vicinity of the affected exon–intron junctions was devoid of alternative splice‐sites. By contrast, in the presence of at least one such motif, cryptic splice‐site utilization, became more prevalent. This association was, however, confined to donor splice‐sites. Outside the obligate dinucleotide, the spatial distribution of pathological mutations was found to differ significantly from that of SNPs. Whereas disease‐associated lesions clustered at positions –1 and +3 to +6 for donor sites and –3 for acceptor sites, SNPs were found to be almost evenly distributed over all sequence positions considered. When all putative missense mutations in the vicinity of splice‐sites were extracted from the Human Gene Mutation Database for the 38 studied genes, a significantly higher proportion of changes at donor sites (37/152; 24.3%) than at acceptor splice‐sites (1/142; 0.7%) was found to reduce the neural network signal emitted by the respective splice‐site. Based upon these findings, we estimate that some 1.6% of disease‐causing missense substitutions in human genes are likely to affect the mRNA splicing phenotype. Taken together, our results are consistent with correct donor splice‐site recognition being a key step in exon recognition. Hum Mutat 28(2), 150–158, 2007.This publication has 33 references indexed in Scilit:
- Splicing in action: assessing disease causing sequence changesJournal of Medical Genetics, 2005
- OAS1 Splice Site Polymorphism Controlling Antiviral Enzyme Activity Influences Susceptibility to Type 1 DiabetesDiabetes, 2005
- Towards a Splicing CodeCell, 2004
- Influence of RNA Secondary Structure on the Pre-mRNA Splicing ProcessMolecular and Cellular Biology, 2004
- Analysis and recognition of 5' UTR intron splice sites in human pre-mRNANucleic Acids Research, 2004
- Pre-mRNA splicing and human diseaseGenes & Development, 2003
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Analysis of canonical and non-canonical splice sites in mammalian genomesNucleic Acids Research, 2000
- Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1Human Molecular Genetics, 2000
- Evidence for a linear search in bimolecular 3′ splice site AG selectionProceedings of the National Academy of Sciences of the United States of America, 2000